Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,420 | 399 | 98.1% |
| Education | $111.55 | 2 | 1.3% |
| Consulting Fee | $50.00 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,494 | 71 | $0 (2024) |
| Amgen Inc. | $1,318 | 60 | $0 (2024) |
| Janssen Biotech, Inc. | $1,211 | 56 | $0 (2024) |
| Celgene Corporation | $816.60 | 41 | $0 (2019) |
| Aurinia Pharma U.S., Inc. | $491.85 | 23 | $0 (2024) |
| UCB, Inc. | $447.89 | 23 | $0 (2024) |
| PFIZER INC. | $367.55 | 17 | $0 (2024) |
| Radius Health, Inc. | $319.57 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $286.63 | 10 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $258.29 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,747 | 75 | Janssen Biotech, Inc. ($376.40) |
| 2023 | $803.10 | 49 | ABBVIE INC. ($212.15) |
| 2022 | $1,273 | 50 | Janssen Biotech, Inc. ($450.55) |
| 2021 | $1,208 | 54 | Amgen Inc. ($461.66) |
| 2020 | $814.68 | 39 | Amgen Inc. ($473.30) |
| 2019 | $1,088 | 66 | Celgene Corporation ($265.53) |
| 2018 | $1,371 | 49 | Celgene Corporation ($478.16) |
| 2017 | $276.48 | 20 | Celgene Corporation ($72.91) |
All Payment Transactions
402 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 12/18/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $2.03 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.53 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | ILARIS (Drug) | Food and Beverage | In-kind items and services | $30.22 | General |
| Category: Immunology | ||||||
| 11/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Endocrinology | ||||||
| 10/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $33.95 | General |
| Category: Not Applicable | ||||||
| 10/19/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $27.43 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Dermatology | ||||||
| 10/08/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $29.39 | General |
| Category: DERMATOLOGY | ||||||
| 09/21/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: IMMUNOLOGY | ||||||
| 08/30/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/30/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $2.28 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: Immunology | ||||||
| 08/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Immunology | ||||||
| 08/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: Immunology | ||||||
| 08/13/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $31.06 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 08/09/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Endocrinology | ||||||
| 08/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 298 | 454 | $120,269 | $32,929 |
| 2022 | 11 | 305 | 476 | $122,679 | $35,686 |
| 2021 | 4 | 148 | 246 | $50,712 | $24,954 |
| 2020 | 9 | 255 | 1,113 | $57,366 | $26,005 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 108 | 230 | $79,350 | $21,278 | 26.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $19,668 | $5,867 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 25 | $6,125 | $1,551 | 25.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 12 | 12 | $1,596 | $904.16 | 56.7% |
| 73120 | X-ray of hand, 2 views | Office | 2023 | 19 | 36 | $3,285 | $744.94 | 22.7% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 13 | 20 | $2,500 | $565.82 | 22.6% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 13 | 13 | $1,287 | $483.80 | 37.6% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 17 | 17 | $2,253 | $441.28 | 19.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 12 | $360.00 | $352.80 | 98.0% |
| 72070 | X-ray of middle spine, 2 views | Office | 2023 | 14 | 14 | $1,470 | $284.83 | 19.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 20 | $780.00 | $236.93 | 30.4% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 11 | 11 | $1,595 | $219.10 | 13.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 103 | 239 | $82,455 | $24,743 | 30.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 45 | 45 | $20,115 | $5,540 | 27.5% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 44 | 44 | $5,085 | $1,894 | 37.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 13 | $3,185 | $880.75 | 27.7% |
| 73562 | X-ray of knee, 3 views | Office | 2022 | 13 | 22 | $2,736 | $696.54 | 25.5% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2022 | 12 | 21 | $2,258 | $519.88 | 23.0% |
| 73120 | X-ray of hand, 2 views | Office | 2022 | 15 | 18 | $2,160 | $404.01 | 18.7% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2022 | 14 | 14 | $1,855 | $396.66 | 21.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 15 | 23 | $897.00 | $286.10 | 31.9% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 11 | 11 | $1,595 | $247.53 | 15.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 21 | 26 | $338.00 | $77.40 | 22.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 89 | 180 | $35,100 | $18,729 | 53.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 30 | 30 | $8,880 | $4,036 | 45.5% |
About Dr. Andrew Phan, M.D
Dr. Andrew Phan, M.D is a Rheumatology healthcare provider based in Orange, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/22/2008. The National Provider Identifier (NPI) number assigned to this provider is 1710164736.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Phan, M.D has received a total of $8,582 in payments from pharmaceutical and medical device companies, with $1,747 received in 2024. These payments were reported across 402 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($8,420).
As a Medicare-enrolled provider, Phan has provided services to 1,006 Medicare beneficiaries, totaling 2,289 services with total Medicare billing of $119,574. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Other Specialties Rheumatology
- Location Orange, CA
- Active Since 01/22/2008
- Last Updated 11/09/2021
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1710164736
Products in Payments
- Otezla (Drug) $1,059
- RINVOQ (Biological) $940.03
- TREMFYA (Drug) $879.56
- Enbrel (Biological) $572.60
- LUPKYNIS (Drug) $491.85
- Cimzia (Drug) $447.89
- REMICADE (Biological) $331.50
- XELJANZ (Drug) $279.44
- EVENITY (Biological) $273.12
- Tymlos (Biological) $235.68
- HUMIRA (Biological) $229.53
- COSENTYX (Biological) $188.26
- BENLYSTA (Biological) $169.37
- ORENCIA (Biological) $159.40
- SAPHNELO (Biological) $133.96
- FASENRA (Drug) $123.17
- Revlimid (Drug) $121.09
- TALTZ (Drug) $109.69
- KEVZARA (Drug) $106.10
- KEVZARA (Biological) $85.50
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Orange
Sheetal Desai, Md, MD
Rheumatology — Payments: $454,444
Dr. Mehrnaz Hojjati, M. D, M. D
Rheumatology — Payments: $94,239
Behnam Khaleghi, Md, MD
Rheumatology — Payments: $59,467
Joo-Hyung Lee, Md, MD
Rheumatology — Payments: $41,818
Thomas Powell, Md, MD
Rheumatology — Payments: $11,619
Michael Cheng, Do, DO
Rheumatology — Payments: $5,336